IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
32 hedge funds and large institutions have $7.54M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.86M | |
| 2 | +$1.2M | |
| 3 | +$956K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$329K |
| 5 |
Renaissance Technologies
New York
|
+$165K |
Top Sellers
| 1 | -$99K | |
| 2 | -$43K | |
| 3 | -$33.9K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$19.3K |
| 5 |
Morgan Stanley
New York
|
-$1.23K |